Clinically significant ticagrelor induced conduction abnormalities following percutaneous coronary intervention

Int J Cardiol. 2016 Jul 1:214:21-2. doi: 10.1016/j.ijcard.2016.03.143. Epub 2016 Mar 24.

Authors

Nevin C Baker¹, Wadih Nadour², Mati Friehling³

Affiliations

¹ Department of Interventional Cardiology, Excela Health Westmoreland Hospital, United States. Electronic address: Nbaker@excelahealth.org.
² Department of Interventional Cardiology, Excela Health Westmoreland Hospital, United States.
³ Department of Electrophysiology, Excela Health Westmoreland Hospital, United States.

PMID: 27057966
DOI: 10.1016/j.ijcard.2016.03.143

No abstract available

Keywords: Acute coronary syndrome; Atrioventricular block; Bradycardia; Ticagrelor.

Publication types

Case Reports

MeSH terms

Acute Coronary Syndrome / diagnostic imaging
Acute Coronary Syndrome / therapy*
Adenosine / adverse effects
Adenosine / analogs & derivatives*
Atrioventricular Block / chemically induced
Atrioventricular Block / drug therapy*
Coronary Angiography
Drug-Eluting Stents
Humans
Male
Middle Aged
Percutaneous Coronary Intervention / methods*
Prasugrel Hydrochloride / therapeutic use
Ticagrelor
Treatment Outcome

Substances

Prasugrel Hydrochloride
Ticagrelor
Adenosine